DNA Vaccination Against Cholesterol Ester Transfer Protein in the Treatment of Atherosclerosis

Details for Australian Patent Application No. 2002318783 (hide)

Owner Pharmacia Corporation

Inventors Glenn, Kevin; Needleman, Philip

Agent EF WELLINGTON & CO

Pub. Number AU-A-2002318783

Parent 92317

Filing date 17 December 2002

Wipo publication date 10 April 2003

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

9 January 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

  Published as AU-A-2002318783

27 November 2003 Assignment before Grant

  Pharmacia Corporation The application has been assigned to Avant Immunotherapeutics Inc.

3 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318784-Overlapping Triangle Meshes

2002318782-Stringline Guide System